Differential partitioning of Gαi1 with the cellular microtubules: a possible mechanism of development of Taxol resistance in human ovarian carcinoma cells

由 Parekh, Hemant K, Adikari, Mahesha, Vennapusa, Bharathi
出版 2006

Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer

由 Li, Yijin, Vennapusa, Bharathi, Chang, Ching-Wei, Tran, David, Nakamura, Rin, Sumiyoshi, Teiko, Hegde, Priti, Molinero, Luciana
發表在 Appl Immunohistochem Mol Morphol (2021)

Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N

由 Smith, Jacquelyn, Robida, Mark D., Acosta, Krista, Vennapusa, Bharathi, Mistry, Amita, Martin, Greg, Yates, Alton, Hnatyszyn, H. James
發表在 Diagn Pathol (2016)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma

由 Kaseb, Ahmed Omar, Hassan, Manal, Lacin, Sahin, Abdel-Wahab, Reham, Amin, Hesham M., Shalaby, Ahmed, Wolff, Robert A., Yao, James, Rashid, Asif, Vennapusa, Bharathi, Feng, Janine, Ohtomo, Toshihiko
發表在 Oncotarget (2016)

Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab

由 Vennapusa, Bharathi, Baker, Brian, Kowanetz, Marcin, Boone, Jennifer, Menzl, Ina, Bruey, Jean-Marie, Fine, Gregg, Mariathasan, Sanjeev, McCaffery, Ian, Mocci, Simonetta, Rost, Sandra, Smith, Dustin, Dennis, Eslie, Tang, Szu-Yu, Damadzadeh, Bita, Walker, Espen, Hegde, Priti S., Williams, J. Andrew, Koeppen, Hartmut, Boyd, Zachary
發表在 Appl Immunohistochem Mol Morphol (2019)

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

由 Rudin, Charles M, Pietanza, M Catherine, Bauer, Todd M, Ready, Neal, Morgensztern, Daniel, Glisson, Bonnie S, Byers, Lauren A, Johnson, Melissa L, Burris, Howard A, Robert, Francisco, Han, Tae H, Bheddah, Sheila, Theiss, Noah, Watson, Sky, Mathur, Deepan, Vennapusa, Bharathi, Zayed, Hany, Lally, Satwant, Strickland, Donald K, Govindan, Ramaswamy, Dylla, Scott J, Peng, Stanford L, Spigel, David R
發表在 Lancet Oncol (2016)